Tissue requirements for establishing long-term CD4+ T cell-mediated immunity following Leishmania donovani infection

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3709-3718

  Bunn, Patrick T ^a,b   Stanley, Amanda C ^a,c   De Labastida Rivera, Fabian ^a   Mulherin, Alexander ^a,d   Sheel, Meru ^a   Alexander, Clare E ^e   Faleiro, Rebecca J ^a,f   Amante, Fiona H ^a   De Oca, Marcela Montes ^a,c   Best, Shannon E ^a   James, Kylie R ^a,c   Kaye, Paul M ^g   Haque, Ashraful ^a   Engwerda, Christian R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^g UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MICE; MICE, KNOCKOUT; PROPYLENE GLYCOLS; SPHINGOSINE; SPLEEN;

EID: 84898657153     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300768     Document Type: Article

References (55)

1. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132: 31-74.
2. Mebius, R. E., and G. Kraal. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5: 606-616.
3. Boone, K. E., and D. A. Watters. 1995. The incidence of malaria after splenectomy in Papua New Guinea. BMJ 311: 1273.
4. Davidson, R. N., and R. A.Wall. 2001. Prevention and management of infections in patients without a spleen. Clin. Microbiol. Infect. 7: 657-660.
5. Kruetzmann, S., M. M. Rosado, H. Weber, U. Germing, O. Tournilhac, H. H. Peter, R. Berner, A. Peters, T. Boehm, A. Plebani, et al. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197: 939-945.
6. Kaye, P. M., M. Svensson, M. Ato, A. Maroof, R. Polley, S. Stager, S. Zubairi, and C. R. Engwerda. 2004. The immunopathology of experimental visceral leishmaniasis. Immunol. Rev. 201: 239-253.
7. Stanley, A. C., and C. R. Engwerda. 2007. Balancing immunity and pathology in visceral leishmaniasis. Immunol. Cell Biol. 85: 138-147.
8. Engwerda, C. R., and P. M. Kaye. 2000. Organ-specific immune responses associated with infectious disease. Immunol. Today 21: 73-78.
9. Smelt, S. C., C. R. Engwerda, M. McCrossen, and P. M. Kaye. 1997. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J. Immunol. 158: 3813-3821.
10. Bryceson, A. 1996. Tropical medicine for the 21st century. Tropical medicine should be concerned with medical problems endemic to the tropics. BMJ 312: 247.
11. Wilson, M. E., M. Sandor, A. M. Blum, B. M. Young, A. Metwali, D. Elliott, R. G. Lynch, and J. V. Weinstock. 1996. Local suppression of IFN-γamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 156: 2231-2239.
12. Crocker, P. R., J. M. Blackwell, and D. J. Bradley. 1984. Expression of the natural resistance gene Lsh in resident liver macrophages. Infect. Immun. 43: 1033-1040.
13. McElrath, M. J., H. W. Murray, and Z. A. Cohn. 1988. The dynamics of granuloma formation in experimental visceral leishmaniasis. J. Exp. Med. 167: 1927-1937.
14. Murray, H. W. 2001. Tissue granuloma structure-function in experimental visceral leishmaniasis. Int. J. Exp. Pathol. 82: 249-267.
15. Murray, H. W., J. Hariprashad, and R. E. Fichtl. 1996. Models of relapse of experimental visceral leishmaniasis. J. Infect. Dis. 173: 1041-1043.
16. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
17. Sean Riminton, D., H. Körner, D. H. Strickland, F. A. Lemckert, J. D. Pollard, and J. D. Sedgwick. 1998. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187: 1517-1528.
18. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha-and betachain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
19. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
20. Haque, A., S. E. Best, A. Ammerdorffer, L. Desbarrieres, M. M. de Oca, F. H. Amante, F. de Labastida Rivera, P. Hertzog, G. M. Boyle, G. R. Hill, and C. R. Engwerda. 2011. Type I interferons suppress CD4+ T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 41: 2688-2698.
21. deWalick, S., F. H. Amante, K. A. McSweeney, L. M. Randall, A. C. Stanley, A. Haque, R. D. Kuns, K. P. MacDonald, G. R. Hill, and C. R. Engwerda. 2007. Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J. Immunol. 178: 6033-6037.
22. Polley, R., S. Stager, S. Prickett, A. Maroof, S. Zubairi, D. F. Smith, and P. M. Kaye. 2006. Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infect. Immun. 74: 773-776.
23. Haque, A., A. C. Stanley, F. H. Amante, Fde. L. Rivera, Y. Zhou, R. D. Kuns, V. Yardley, S. Sakaguchi, G. R. Hill, and C. R. Engwerda. 2010. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity. J. Immunol. 184: 2583-2592.
24. Stanley, A. C., Y. Zhou, F. H. Amante, L. M. Randall, A. Haque, D. G. Pellicci, G. R. Hill, M. J. Smyth, D. I. Godfrey, and C. R. Engwerda. 2008. Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. PLoS Pathog. 4: e1000028.
25. Stanley, A. C., J. E. Dalton, S. H. Rossotti, K. P. MacDonald, Y. Zhou, F. Rivera, W. A. Schroder, A. Maroof, G. R. Hill, P. M. Kaye, and C. R. Engwerda. 2008. VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog. 4: e1000158.
26. Stanley, A. C., F. de Labastida Rivera, A. Haque, M. Sheel, Y. Zhou, F. H. Amante, P. T. Bunn, L. M. Randall, K. Pfeffer, S. Scheu, et al. 2011. Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection. PLoS Pathog. 7: e1002279.
27. Barbier, L., S. S. Tay, C. McGuffog, J. A. Triccas, G. W. McCaughan, D. G. Bowen, and P. Bertolino. 2012. Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. J. Hepatol. 57: 352-358.
28. Cotterell, S. E., C. R. Engwerda, and P. M. Kaye. 2000. Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani. Infect. Immun. 68: 1840-1848.
29. Cotterell, S. E., C. R. Engwerda, and P. M. Kaye. 2000. Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-αlpha. Blood 95: 1642-1651.
30. Feuerer, M., P. Beckhove, N. Garbi, Y. Mahnke, A. Limmer, M. Hommel, G. J. Hämmerling, B. Kyewski, A. Hamann, V. Umansky, and V. Schirrmacher. 2003. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 9: 1151-1157.
31. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
32. Brinkmann, V., M. D. Davis, C. E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277: 21453-21457.
33. Mandala, S., R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G. J. Shei, D. Card, C. Keohane, et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296: 346-349.
34. Murray, H. W., K. E. Squires, C. D. Miralles, M. Y. Stoeckle, A. M. Granger, A. Granelli-Piperno, and C. Bogdan. 1992. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J. Immunol. 148: 1858-1863.
35. Czeloth, N., A. Schippers, N. Wagner, W. Müller, B. Küster, G. Bernhardt, and R. Förster. 2007. Sphingosine-1 phosphate signaling regulates positioning of dendritic cells within the spleen. J. Immunol. 179: 5855-5863.
36. Taylor, P. A., M. J. Ehrhardt, C. J. Lees, J. Tolar, B. J. Weigel, A. Panoskaltsis-Mortari, J. S. Serody, V. Brinkmann, and B. R. Blazar. 2007. Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood 110: 3480-3488.
37. Butler, N. S., J. Moebius, L. L. Pewe, B. Traore, O. K. Doumbo, L. T. Tygrett, T. J. Waldschmidt, P. D. Crompton, and J. T. Harty. 2011. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat. Immunol. 13: 188-195.
38. Bryceson, A. D. M. 1996. Leishmaniasis. In Manson's Tropical Diseases, 20th Ed. G. C. Cook, ed. W. B. Saunders, London, p. 1213-1245.
39. Takada, K., and S. C. Jameson. 2009. Naive T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 9: 823-832.
40. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
41. Sacks, D. L., S. L. Lal, S. N. Shrivastava, J. Blackwell, and F. A. Neva. 1987. An analysis of T cell responsiveness in Indian kala-azar. J. Immunol. 138: 908-913.
42. Ansari, N. A., R. Kumar, S. Gautam, S. Nylén, O. P. Singh, S. Sundar, and D. Sacks. 2011. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J. Immunol. 186: 3977-3985.
43. Gidwani, K., A. Picado, S. Rijal, S. P. Singh, L. Roy, V. Volfova, E.W. Andersen, S. Uranw, B. Ostyn, M. Sudarshan, et al. 2011. Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl. Trop. Dis. 5: e1296.
44. Singh, O. P., K. Gidwani, R. Kumar, S. Nylén, S. L. Jones, M. Boelaert, D. Sacks, and S. Sundar. 2012. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin. Vaccine Immunol. 19: 961-966.
45. Gautam, S., R. Kumar, R. Maurya, S. Nylén, N. Ansari, M. Rai, S. Sundar, and D. Sacks. 2011. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J. Infect. Dis. 204: 1134-1137.
46. Greter, M., J. Hofmann, and B. Becher. 2009. Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity. PLoS Biol. 7: e1000109.
47. Moyron-Quiroz, J. E., J. Rangel-Moreno, K. Kusser, L. Hartson, F. Sprague, S. Goodrich, D. L. Woodland, F. E. Lund, and T. D. Randall. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10: 927-934.
48. Klein, I., and I. N. Crispe. 2006. Complete differentiation of CD8+ T cells activated locally within the transplanted liver. J. Exp. Med. 203: 437-447.
49. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a namë Nat. Rev. Immunol. 4: 231-237.
50. Beattie, L., A. Peltan, A. Maroof, A. Kirby, N. Brown, M. Coles, D. F. Smith, and P. M. Kaye. 2010. Dynamic imaging of experimental Leishmania donovaniinduced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells. PLoS Pathog. 6: e1000805.
51. Albergante, L., J. Timmis, L. Beattie, and P. M. Kaye. 2013. A Petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani infection. PLOS Comput. Biol. 9: e1003334.
52. Fakiola, M., A. Strange, H. J. Cordell, E. N. Miller, M. Pirinen, Z. Su, A. Mishra, S. Mehrotra, G. R. Monteiro, G. Band, et al; LeishGEN Consortium; Wellcome Trust Case Control Consortium 2. 2013. Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat. Genet. 45: 208-213.
53. Morris, M. A., D. R. Gibb, F. Picard, V. Brinkmann, M. Straume, and K. Ley. 2005. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720. Eur. J. Immunol. 35: 3570-3580.
54. Engwerda, C. R., M. Ato, S. Stäger, C. E. Alexander, A. C. Stanley, and P. M. Kaye. 2004. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am. J. Pathol. 165: 2123-2133.
55. Alexander, C. E., P. M. Kaye, and C. R. Engwerda. 2001. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur. J. Immunol. 31: 1199-1210.